These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36978228)

  • 41. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
    Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of tolerance to heart allografts in rats using posttransplant total lymphoid irradiation and anti-T cell antibodies.
    Woodley SL; Gurley KE; Hoffmann SL; Nicolls MR; Hagberg R; Clayberger C; Holm B; Wang X; Hall BM; Strober S
    Transplantation; 1993 Dec; 56(6):1443-7. PubMed ID: 8279017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade.
    Gao D; Lunsford KE; Eiring AM; Bumgardner GL
    Am J Transplant; 2004 Jul; 4(7):1061-70. PubMed ID: 15196062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection.
    Setoguchi K; Hattori Y; Iida S; Baldwin WM; Fairchild RL
    Am J Transplant; 2013 Sep; 13(9):2293-307. PubMed ID: 23914930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting LFA-1 and cd154 suppresses the in vivo activation and development of cytolytic (cd4-Independent) CD8+ T cells.
    Lunsford KE; Koester MA; Eiring AM; Horne PH; Gao D; Bumgardner GL
    J Immunol; 2005 Dec; 175(12):7855-66. PubMed ID: 16339521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway.
    van Maurik A; Wood KJ; Jones ND
    Transplantation; 2002 Sep; 74(5):740-3. PubMed ID: 12352896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
    Uppaluri R; Sheehan KC; Wang L; Bui JD; Brotman JJ; Lu B; Gerard C; Hancock WW; Schreiber RD
    Transplantation; 2008 Jul; 86(1):137-47. PubMed ID: 18622291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells.
    Gorbacheva V; Ayasoufi K; Fan R; Baldwin WM; Valujskikh A
    Am J Transplant; 2015 Feb; 15(2):346-57. PubMed ID: 25496308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
    Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.
    Lal G; Nakayama Y; Sethi A; Singh AK; Burrell BE; Kulkarni N; Brinkman CC; Iwami D; Zhang T; Bromberg JS
    Transplantation; 2015 Sep; 99(9):1817-28. PubMed ID: 25839706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
    Hotta K; Oura T; Dehnadi A; Boskovic S; Matsunami M; Rosales I; Smith RN; Colvin RB; Cosimi AB; Kawai T
    Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions.
    Wang CY; Mazer SP; Minamoto K; Takuma S; Homma S; Yellin M; Chess L; Fard A; Kalled SL; Oz MC; Pinsky DJ
    Circulation; 2002 Apr; 105(13):1609-14. PubMed ID: 11927531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.